Synopsis of recent research by authors named "Yanyi Xiao"
- Yanyi Xiao's recent research primarily focuses on cancer biology, particularly exploring the therapeutic effects of various compounds on pancreatic and breast cancers, with a notable emphasis on the signaling pathways involved in tumor progression and metastasis.
- Key findings include the potential of nomilin against triple-negative breast cancer, the role of lymphocyte antigen 6 family member E and PI3K/AKT/mTOR pathway in pancreatic cancer proliferation, and the utilization of agents like chloroxine and sophocarpine in inhibiting cancer progression.
- Xiao's articles emphasize a multidisciplinary approach incorporating network pharmacology, molecular docking, and experimental validation to understand the molecular mechanisms behind these therapeutic effects, highlighting the need for effective treatments in cancer types with high mortality rates.
